The DOTS strategy for controlling the global tuberculosis epidemic

Clinics in Chest Medicine

Volumn 26, Issue 2, 2005, Pages 197-205

  Frieden, Thomas R ^a   Munsiff, Sonal S ^a,b  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RIFAMYCIN;

ALGORITHM; CHEMOTHERAPY; CLINICAL OBSERVATION; DIAGNOSTIC PROCEDURE; DRUG QUALITY; DRUG SENSITIVITY; EPIDEMIC; HEALTH CARE FACILITY; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROSCOPY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATIENT; PATIENT MONITORING; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SCIENCE; SPUTUM ANALYSIS; SPUTUM SMEAR; STANDARDIZATION; TREATMENT INDICATION; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 17044384970     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.02.001     Document Type: Review

References (100)

1. WHO calls for immediate use of new tuberculosis breakthrough [press release WHO/24, 1997] March 21, 1997 World Health Organization Geneva (Switzerland)
2. C.J. Murray, E. DeJonghe, and H.J. Chum Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries Lancet 338 8778 1991 1305 1308
3. An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297 2002 World Health Organization Global Tuberculosis Programme Geneva (Switzerland)
4. Global tuberculosis control: surveillance, planning, financing. WHO Report 2005. WHO/HTM/TB/2005.49 2005 World Health Organization Geneva (Switzerland)
5. The world health report 2004: changing history 2004 World Health Organization Geneva (Switzerland)
6. TB deaths reach historic levels [press release WHO/22, 1996] March 21, 1996 World Health Organization Geneva (Switzerland)
7. Groups at risk: WHO report on the tuberculosis epidemic 1996. WHO/TB/96.198 1996 World Health Organization Geneva (Switzerland)
8. R.R. Newell, W.E. Chamberlain, and L. Rigler Descriptive classification of pulmonary shadows: a revelation of unreliability in the roentgenographic diagnosis of tuberculosis Am Rev Tuberc 69 4 1954 566 584
9. L.H. Garland Studies on the accuracy of diagnostic procedures Am J Roentgenol Radium Ther Nucl Med 82 1 1959 25 38
10. R. Koppaka, and N. Bock How reliable is chest radiography? T. Frieden Toman's tuberculosis: case detection, treatment, and monitoring-questions and answers 2nd edition 2004 World Health Organization Geneva (Switzerland) 51 60
11. A. Harries What are the relative merits of chest radiography and sputum examination (smear microscopy and culture) in case detection among new outpatients with prolonged chest symptoms? T. Frieden Toman's tuberculosis: case detection, treatment, and monitoring-questions and answers 2nd edition 2004 World Health Organization Geneva (Switzerland) 61 65
12. K. Styblo Epidemiology of tuberculosis 1991 Royal Netherlands Tuberculosis Association The Hague (The Netherlands)
13. A. Rouillon, S. Perdrizet, and R. Parrot Transmission of tubercle bacilli: the effects of chemotherapy Tubercle 57 4 1976 275 299
14. T. Shimao Tuberculosis case-finding. WHO/TB/82.131 1982 World Health Organization Geneva (Switzerland)
15. Treatment of tuberculosis: guidelines for national programmes. 3rd edition. WHO/CDS/TB/2003.313 2003 World Health Organization Geneva (Switzerland)
16. R. Urbanczik Present position of microscopy and of culture in diagnostic mycobacteriology Zentralbl Bakteriol Mikrobiol Hyg [A] 260 1 1985 81 87
17. American Thoracic Society Workshop Rapid diagnostic tests for tuberculosis: what is the appropriate use? Am J Respir Crit Care Med 155 5 1997 1804 1814
18. H. Rieder What is the role of case detection by periodic mass radiographic examination in tuberculosis control? T. Frieden Toman's tuberculosis: case detection, treatment, and monitoring-questions and answers 2nd edition 2004 World Health Organization Geneva (Switzerland) 72 79
19. D. Banerji, and S. Anderson A sociological study of awareness of symptoms among persons with pulmonary tuberculosis Bull World Health Organ 26 1963 665 683
20. Interim policy on collaborative TB/HIV activities. WHO/HTM/TB/2004 2004 World Health Organization Geneva (Switzerland)
21. D.A. Mitchison, and A.J. Nunn Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis Am Rev Respir Dis 133 3 1986 423 430
22. Hong Kong Chest Service/British Medical Research Council Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis Am Rev Respir Dis 136 6 1987 1339 1342
23. Singapore Tuberculosis Service/British Medical Research Council Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis Am Rev Respir Dis 137 5 1988 1147 1150
24. D.L. Cohn, B.J. Catlin, and K.L. Peterson A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen Ann Intern Med 112 6 1990 407 415
25. R.E. Chaisson, H.C. Clermont, and E.A. Holt Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection Am J Respir Crit Care Med 154 4 Pt 1 1996 1034 1038
26. R. Balasubramanian, and R. Ramachandran Management of non-pulmonary forms of tuberculosis: review of TRC studies over two decades Indian J Pediatr 67 2 Suppl 2000 34 40
27. A.P. Yuen, S.H. Wong, and C.M. Tam Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy Otolaryngol Head Neck Surg 116 2 1997 189 192
28. T.R. Frieden, T.R. Sterling, and S.S. Munsiff Tuberculosis Lancet 362 9387 2003 887 899
29. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Treatment of tuberculosis Am J Respir Crit Care Med 167 4 2003 603 662
30. R. Balasubramanian, S. Sivasubramanian, and V.K. Vijayan Five-year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in South India Tubercle 71 4 1990 253 258
31. Singapore Tuberculosis Service/British Medical Research Council Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis Am Rev Respir Dis 119 4 1979 579 585
32. R.J. North, and A.A. Izzo Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity J Exp Med 177 6 1993 1723 1733
33. D.A. Mitchison, and J.M. Dickinson Laboratory aspects of intermittent drug therapy Postgrad Med J 47 553 1971 737 741
34. M. Datta, M.P. Radhmani, and R. Selvaraj Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme Tuber Lung Dis 74 3 1993 180 186
35. Warning to readers. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens MMWR Morb Mortal Wkly Rep 51 10 2002 214 215
36. Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. January 20, 2004 Available at: http://www.cdc.gov/nchstp/tb/tb_hiv_drugs/toc.htm Accessed January 28, 2005
37. S. Grzybowski Drugs are not enough: failure of short-course chemotherapy in a district in India Tuber Lung Dis 74 3 1993 145 146
38. D.A. Mitchison Basic mechanisms of chemotherapy Chest 76 6 Suppl 1979 771 781
39. M.D. Iseman, D.L. Cohn, and J.A. Sbarbaro Directly observed treatment of tuberculosis: we can't afford not to try it N Engl J Med 328 8 1993 576 578
40. W. Fox Compliance of patients and physicians: experience and lessons from tuberculosis I BMJ 287 6384 1993 33 35
41. J.A. Sbarbaro The patient-physician relationship: compliance revisited Ann Allergy 64 4 1990 325 331
42. R.B. Haynes, K.A. McKibbon, and R. Kanani Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications [published erratum in Lancet 1997;349(9059):1180] Lancet 348 9024 1996 383 386
43. A. Pablos-Mendez, C.A. Knirsch, and R.G. Barr Nonadherence in tuberculosis treatment: predictors and consequences in New York City Am J Med 102 2 1997 164 170
44. W. Fox The problem of self-administration of drugs, with particular reference to pulmonary tuberculosis Tubercle 39 5 1958 269 274
45. W. Fox Self-administration of medicaments. A review of published work and a study of the problems Bull Int Union Tuberc 32 1962 307 331
46. C.J. Murray, E. DeJonghe, and H.J. Chum Cost-effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries Lancet 338 8778 1991 1305 1308
47. E. Heldal, J.R. Cruz, and T. Arnadottir Successful management of a national tuberculosis programme under conditions of war Int J Tuberc Lung Dis 1 1 1997 16 24
48. L.X. Zhang, and G.Q. Kan Tuberculosis control programme in Beijing Tuber Lung Dis 73 3 1992 162 166
49. P.I. Fujiwara, C. Larkin, and T.R. Frieden Directly observed therapy in New York City: history, implementation, results, and challenges Clin Chest Med 18 1 1997 135 148
50. D. Wilkinson High-compliance tuberculosis treatment programme in a rural community Lancet 343 8898 1994 647 648
51. D. Wilkinson, and G.R. Davies Coping with Africa's increasing tuberculosis burden: are community supervisors an essential component of the DOT strategy? Trop Med Int Health 2 7 1997 700 704
52. A.M. Chowdhury, S. Chowdhury, and M.N. Islam Control of tuberculosis by community health workers in Bangladesh [published erratum in Lancet 1997;350(9084):1108] Lancet 350 9072 1997 169 172
53. F. Manalo, F. Tan, and J.A. Sbarbaro Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance Am Rev Respir Dis 142 6 Pt 1 1990 1301 1305
54. G.R. Khatri, and T.R. Frieden Controlling tuberculosis in India N Engl J Med 347 18 2002 1420 1425
55. S.H. Miles, and R.B. Maat A successful supervised outpatient short-course tuberculosis treatment program in an open refugee camp on the Thai-Cambodian border Am Rev Respir Dis 130 5 1984 827 830
56. T.R. Frieden, and C.R. Driver Tuberculosis control: past 10 years and future progress Tuberculosis (Edinb) 83 1-3 2003 82 85
57. T. Frieden, and J.A. Sbarbaro The slippery slope to sloppy DOTS Int J Tuberc Lung Dis 6 5 2002 371 372
58. W. Fox, G.A. Ellard, and D.A. Mitchison Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications Int J Tuberc Lung Dis 3 10 Suppl 2 1999 231 279
59. C.P. Chaulk, K. Moore-Rice, and R. Rizzo Eleven years of community-based directly observed therapy for tuberculosis JAMA 274 12 1995 945 951
60. T.R. Frieden, T. Sterling, and A. Pablos-Mendez The emergence of drug resistant tuberculosis in New York City [published erratum in N Engl J Med 1993;329(2):148] N Engl J Med 328 8 1993 521 526
61. T.R. Frieden, P.I. Fujiwara, and R.M. Washko Tuberculosis in New York City-turning the tide N Engl J Med 333 4 1995 229 233
62. E. Gonzalez, L. Armas, and A. Alonso Tuberculosis in the Republic of Cuba: its possible elimination Tuber Lung Dis 75 3 1994 188 194
63. P. Suárez, C.J. Watt, and E. Alarcon The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru J Infect Dis 184 4 2001 473 478
64. China Tuberculosis Control Collaboration The effect of tuberculosis control in China Lancet 364 9432 2004 417 422
65. H. Sawert, S. Kongsin, and V. Payanandana Costs and benefits of improving tuberculosis control: the case of Thailand Soc Sci Med 44 12 1997 1805 1816
66. J. Crofton, P. Chaulet, and D. Maher Guidelines for the management of drug-resistant tuberculosis. WHO/TB/96.210 1996 World Health Organization Geneva (Switzerland)
67. H.J. Chum, R.J. O'Brien, and T.M. Chonde An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993 AIDS 10 3 1996 299 309
68. J.R. Glynn, P.A. Jenkins, and P.E. Fine Patterns of initial and acquired antituberculosis drug resistance in Karonga District, Malawi Lancet 345 8954 1995 907 910
69. J. Crofton The contribution of chemotherapy to the control of tuberculosis as a community disease Thorax 20 1 1971 49 54
70. A. Khalil, and S. Sathianathan Impact of anti-tuberculosis legislation in Libya on the prevalence of primary and acquired resistance to the three main drugs at a major tuberculosis centre Tubercle 59 1 1978 1 12
71. S.J. Kim, G.H. Bai, and Y.P. Hong Drug-resistant tuberculosis in Korea, 1994 Int J Tuber Lung Dis 1 4 1997 302 308
72. S. Ledru, B. Cauchoix, and M. Yameogo Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso Tuber Lung Dis 77 5 1996 429 436
73. L.X. Zhang, G.Q. Kan, and D.H. Tu Trend of initial drug resistance of tubercle bacilli isolated from new patients with pulmonary tuberculosis and its correlation with the tuberculosis programme in Beijing Tuber Lung Dis 76 2 1995 100 103
74. S.E. Weis, P.C. Slocum, and F.X. Blais The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis N Engl J Med 330 17 1994 1179 1184
75. K. Weyer, and H.H. Kleeberg Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement Tuber Lung Dis 73 2 1992 106 112
76. T.R. Sterling, H.P. Lehmann, and T.R. Frieden Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis BMJ 326 7389 2003 574 579
77. C. Dye, M.A. Espinal, and C.J. Watt Worldwide incidence of multidrug-resistant tuberculosis J Infect Dis 185 8 2002 1197 1202
78. Anti-tuberculosis drug resistance in the world: report no. 3, prevalence and trends. WHO/HTM/TB/2004.343 2004 World Health Organization Geneva (Switzerland)
79. C. Mitnick, J. Bayona, and E. Palacios Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru N Engl J Med 348 2 2003 119 128
80. Guidelines for establishing DOTS-PLUS pilot projects for the management of multidrug-resistant tuberculosis (MDRTB). WHO/CDS/TB/2000.279 2000 World Health Organization Geneva (Switzerland)
81. J.S. Mukherjee, M.L. Rich, and A.R. Socci Programmes and principles in treatment of multidrug-resistant tuberculosis Lancet 363 9407 2004 474 481
82. L.E. Thorpe, T.R. Frieden, and K.F. Laserson Seasonality of tuberculosis in India: is it real and what does it tell us? Lancet 364 9445 2004 1613 1614
83. T.R. Frieden, L.F. Sherman, and K.L. Maw A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes JAMA 276 15 1996 1229 1235
84. E. Nathanson, R. Gupta, and P. Huamani Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS plus initiative Int J Tuberc Lung Dis 8 11 2004 1382 1384
85. P.A. Selwyn, D. Hartel, and V.A. Lewis A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection N Engl J Med 320 9 1989 545 550
86. S.W. Dooley, M.E. Villarino, and M. Lawrence Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients JAMA 267 19 1992 2632 2634
87. E.L. Corbett, R.W. Steketee, and F.O. ter Kuile HIV-1/AIDS and the control of other infectious diseases in Africa [published erratum in Lancet 2002;360(9340):1178] Lancet 359 9324 2002 2177 2187
88. M.F. Cantwell, and N.J. Binkin Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and national tuberculosis control program quality Tuber Lung Dis 77 3 1996 220 226
89. Guidelines for implementing collaborative TB and HIV programme activities. WHO/CDS/TB/2003.319 2003 World Health Organization Geneva (Switzerland)
90. Guidelines for HIV surveillance among tuberculosis patients. 2nd edition. WHO/HTM/TB/2004.339 2004 World Health Organization Geneva (Switzerland)
91. TB/HIV. A clinical manual. 2nd edition. WHO/HTM/TB/2004.329 2004 World Health Organization Geneva (Switzerland)
92. J.L. Jones, D.L. Hanson, and M.S. Dworkin HIV-associated tuberculosis in the era of highly active antiretroviral therapy Int J Tuberc Lung Dis 4 11 2000 1026 1031
93. M. Badri, D. Wilson, and R. Wood Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study Lancet 359 9323 2002 2059 2064
94. A.D. Harries Tuberculosis in Africa: clinical presentation and management Pharmacol Ther 73 1 1997 1 50
95. P.M. Small, G.F. Schecter, and P.C. Goodman Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection N Engl J Med 324 5 1991 289 294
96. J.H. Perriens, M.E. St Louis, and Y.B. Mukadi Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months N Engl J Med 332 12 1995 779 784
97. A. Okwera, C. Whalen, and F. Byekwaso Randomized trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans Lancet 344 8933 1994 1323 1328
98. K. Alwood, J. Keruly, and K. Moore-Rice Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients AIDS 8 8 1994 1103 1108
99. P.L. Alpert, S.S. Munsiff, and M.N. Gourevitch A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival Clin Infect Dis 24 4 1997 661 668
100. Department of Health and Human Services Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. October 29, 2004 Available at: http://aidsinfo.nih.gov/guidelines/adult/AA_102904.pdf Accessed January 28, 2005